期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌术后系统性辅助治疗的现状和进展 被引量：10

Current status and advances in adjuvant therapy of operable breast cancer
暂未订购
导出
摘要 辅助治疗是可手术乳腺癌综合治疗的重要组成部分,了解乳腺癌辅助治疗的进展,选择合理的辅助治 疗方案,对提高乳腺癌患者术后的长期生存率有重要的意义。 The widespread application of adjuvant therapy has shown clear benefits in the treatment of operable breast cancer. It is essential for the clinicians to select appropriate adjuvant regimens for this heterogeneous group of patients. Recent data from clinical trials evaluating the utility of adjuvant therapy were reviewed.
作者 沈坤炜 沈镇宙
机构地区 复旦大学附属肿瘤医院乳腺外科
出处 《中国癌症杂志》 CAS CSCD 2003年第4期293-296,共4页 China Oncology
关键词 乳腺癌 术后 系统性辅助治疗 现状 进展 breast cancer adjuvant therapy
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights:International consensus panel on the treatment of primary breast cancer[J]. J Natl Cancer Inst, 1998,90(21 ) :1601-1608.
  • 2Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights:International consensus panel on the treatment of primary breast cancer, seventh international conference on adjuvant therapy of primary breast cancer[J]. J Clin Oncol,2001,19(18) :3817-27.
  • 3National Institutes of Health Consensus Development Conference[M]. J Nail Cancer Inst Monogr,2001,30 : 151-152.
  • 4Carlson RW, Edge SB, Theriault RL. NCCN: Breast cancer[J] ,Cancer Control,2001,8(6) :54-61.
  • 5Elary Breast Cancer Treatment Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials[ J ]. Lancet, 1998,352 ( 2 ) : 930-042.
  • 6Nabholtz JM, Pienkowski T, Mackey J, et al. Phase Ⅲ trial comparing TAC with FAC in the adjuvant ueatment of node positive breast cancer patients: interim analysis[A]. ASCO 2002.
  • 7Citron ML, Berry DA, Cirrincione C, et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concureeent combination chemotherapy as posterative adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741/Cancer and Leukemia Group B trial 9741[J]. J Clin Oncol,2003,21 (7) : 1431-1439.
  • 8Fisher B, Anderson S, Wolmark N, et al. Chemotherapy with or without utmoxifen for patients with ER-negative breast cancer and negative nodes: Result from NSABP B23[ J ]. J Clin Oncol,2001,19(4) :931-942.
  • 9Hutchins L, Green S, Ravdin P, eta 1. CMF versus CAF with and without tamoxifen in highrisk node negative breast cancer patients and a natund histroy follow-up study in low-risk node negative patients:First results of Intergroup trial INT 0102[J].Proc Am Soc Clin Oncol,1998,17:la.
  • 10Levine M, Bramwell V, Pritchard K, et al. Randomized trial of intensive cyclophosphamide,epirubicin, and fluorouracil chemotherapy compared with cyclophoephamide, methotrexate and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group[J]. J Clin Oncol, 1998,16(8) :2651-2658.

同被引文献102

引证文献10

二级引证文献28

中国癌症杂志
2003年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部